Evaxion Biotech AS (EVAX) stock has reached a new 52-week low, touching down at $3.06, with InvestingPro data showing the stock's RSI indicating oversold territory. The company faces a challenging ...

The authors present new expression analysis software (TEKRABber) to help analyze expression correlations between transposable elements (TEs) and KRAB zinc finger (KRAB-ZNF) genes in experimentaly ...

Trailhead Biosystems, a pioneering biotechnology company specializing in the development of iPSC-derived human cells for drug discovery and cell therapy, is pleased to announce the appointment of Dr.

Hervolution Therapeutics ApS (formerly Inprother Aps) has announced a $11.7 million series A financing to support its work developing novel human endogenous retrovirus (HERV)-targeted immunotherapies ...